Read this company snapshot
Daily valuation snapshot
Sunshine Biopharma Inc.: source evidence dated 2026-10-09.
- Daily close (USD)
- $0.34
- Market capitalization (USD)
- $1,309,764.44
- Price / earnings (TTM)
- Not reported
- Price / book
- 0.05
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research SBFM in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research SBFM in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing SBFM with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $0.34 |
| Market capitalization (USD) | $1,309,764.44 |
| Price / earnings (TTM) | Not reported |
| Price / book | 0.05 |
No matching rows. Clear the filter to see all records.
Read SBFM's valuation metrics
Company size
Sunshine Biopharma Inc.'s recorded market capitalization is $1,309,764.44. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
SBFM's recorded price-to-book ratio is 0.05. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Sunshine Biopharma Inc. with Aurora
Use the snapshot above to ask a specific question about SBFM. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow SBFM's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.